Introduction
Cerebrovascular disease encompasses a wide range of causations for the single phenomenon of~ascular compromise to the brain. In anyone patient the evaluation must be tailored to the individual to effect the most accurate diagnosis and to choose the most appropriate treatment. There are sp~cial considerations in the young, female population which add another dimension to the search for aetiology and risk factors for stroke. Horrnonal factors resulting in added risk for women mclude pregnancy, the puerperium, and, more questionably, the use of exogenous oestrogen. In addition, several purported causes of stroke in thẽ oung (migraine, mitral valve prolapse, connective tissue disease, certain vasculitides) occur with greater frequency in women. This paper reviews the epidemiology, risk factors, differential diag-extent, stroke occurring in the young person is not an uncommon phenomenon. According to the National Survey of Stroke, 3.7% of strokes occur in patients aged 15-45 years.? In Florence, Italy, the incidence in patients aged 15-44 was 9.9 per 100000 with no difference between males and females." Despite the overall higher incidence of all stroke subtypes in men when compared to women (all ages inclusive), several studies document a predominance of females in young patients with stroke, particularly in those under the age of 30.4-7This may reflect the differences in aetiology between the sexes, with pregnancy and the puerperium playing an important role in this age group. In fact, Wiebers estimated the likelihood of cerebral infarction during pregnancy was 13 times the rate expected in nonpregnant women of the same age.s Stroke subtype distributions in younger patients tend to be weighted toward haemorrhagic events ( Table 1) . With all ages included, about 85% of strokes are of the ischaemic variety,1,4,9,10 but series describing the younger population are more equally weighted between ischaemic and haemorrhagic subtypes. The incidence of intracerebral haemorrhage is similar in men and women but there is a higher incidence of subarachnoid haemorrhage in women.t! The reasons for this difference are not known.
Causes of ischaemic stroke in the young
Stroke in the young has a more heterogeneous pathogenesis than in the older population and a wide differential must be considered ( Table 2) . Of the entities listed in Table 2 , mitral valve prolapse, migraine, and certain vasculitides occur with greater frequency in women and warrant additional consideration in this population, although conventional risk factors should be considered. Hypertensive encephalopathy102
Systemic hypotension
Risk factors for arteriosclerosis Risk factors in the elderly population primarily consist of those diseases or characteristics predisposing to progression of atherosclerotic disease. Alvarez et al., 12 comparing a group of young (less than age 50 years) patients with stroke to a control population of young hospitalized patients, found that some of these same risk factors (history of peripheral vascular disease, hypertension, tobacco use, or prior stroke) were the only factors reaching significance when compared to the controls. Gandolfo et al., 7 dividing the younger population into two subgroups (ages 15-34 and aged [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] , found risk factors of hypertension, diabetes, hyperlipidaemia, and cardiac disease to be important, but more prevalent in the older subgroup." 
Migraine
The prevalence of migraine in women is greater than in men and has been estimated to be between 23 and 29%.13 Between 5 and 25% of stroke in the young population has been attributed to migraine.l4--18 The diagnosis of migrainous stroke should be made only in a known migraineur who concomitantly experiences a typical migraine headache with the ischaemic symptoms.l 4, 15, 19, 20 Varying definitions for migrainous stroke probably account for some of the variability in reported incidence in the young. There is some evidence for an increased risk of stroke in young women with migraine, particularly when combined with tobacco use and exogenous oestrogen use. 21, 22 Migrainous stroke should be a diagnosis of exclusion. Preventative therapy after stroke should include prophylactic therapy for migraine and attempts to minimize any other stroke risk factors.
Vasculitides
Several of the vasculitides occur with greater frequency in young women including Takayasu disease, vasculitis associated with collagen vascular disease, Moyamoya disease, and fibromuscular dysplasia. 23-28 Evaluation for these entities should include cerebral angiography and serologies to screen for collagen vascular disease. The anti phospholipid antibody syndrome, sometimes occurring concomitantly with collagen vascular disease, should be considered in the young stroke patient. Testing for the lupus anticoagulant and anticardiolipin antibody should be performed, particularly in the patient with a history of vascular headaches, multiple spontaneous abortions, other thrombotic events, livedo reticularis, or thrombocytopenia.s?
Cardioembolic stroke
Studies implicating mitral valve prolapse as a cause for cardioembolic stroke have focused on the young population with otherwise unexplained stroke, reporting widely varying estimations of frequency ranging from 2 to 30% of ischaemic stroke. 3.18,3<J-33 However, recent studies in unselected patients with mitral valve prolapse indicate a low risk of stroke. 34, 35 Although there is a female preponderance for the valvular abnormality, there is no clear sex preponderance for mitral valve prolapse related cerebral infarction.w There is some evidence for the existence of a higher risk group with mitral valve prolapse which includes older patients, males, and those with redundant and thickened leaflets, associated mitral regurgitation, tricuspid valve prolapse, and mitral annulus abnormalities. 37
Risk factors exclusive for the female population
Of course, metabolic changes induced by oral contraceptives and pregnancy and the puerperium are seen exclusively in the young female population. A discussion of stroke in the setting of exogeneous oestrogen use and in pregnancy and the puerperium follows.
Oral contraceptives and stroke
Oral contraceptives (OCs) were initially approved for unrestricted use in 1960. Epidemiological data from the 1960s and early 1970s demonstrated an association between the development of vascular disease and use of the early high-dose oestrogen preparations. 22,3&-41 Since that time proposed pathophysiological mechanisms for the association of OCs with vascular disease and its risk factors have been studied, including effects on blood coagulation, platelet aggregation, circulating lipoprotein, blood pressure, and glucose tolerance. The literature describing these metabolic alterations is incomplete and discrepant.
The impact of OC use on blood coagulation and thrombosis has been extensively reviewed. 42.43 Several alterations of plasma proteins have been described in OC users including increased plasma fibrinogen and the activity of coagulation factors, especially factors VII and X. An OCinduced decrease in the natural anticoagulant antithrombin III may be the most important alteration. Although these data would suppose the production of a prothrombotic state, others have found a concurrent increase in fibrinolysis in OC users which may counteract the prothrombotic effect.P Increases in platelet count and platelet aggregability have been reported. Although some have found an increase in the platelet production of thromboxane A 2, which increases platelet aggregation, others have shown an increase in vessel wall prostacyclin which would prevent platelet aggregation.s-Another serum protein, angiotensinogen, shows a dose-related increase and may be the cause of a small but significant increase in blood pressure.v
The oestrogen and progestogen components of OCs have opposing effects on lipid metabolism. Oestrogen increases total cholesterol and HDL cholesterol and decreases LDL cholesterol, while the synthetic analogues of progesterone used in OCs decrease total and HDL cholesterol and increase LDL cholesterol.w However, the newer progestogens and lower dose preparations may have a neutral or even beneficial effect on lipoprotein metabolism. 47 ,48 Another metabolic alteration induced by the progestogen component is deterioration of glucose tolerance, which also appears to be a dose-related phenomenon.s?
Case-control studies and large prospective cohort studies assessing the vascular morbidity and mortality from the early 1960s through the 1970s concluded that there was an increased risk of ischaemic and in some cases haemorrhagic stroke with oral contraceptive use.J8-41 Attribut-.able risk of thrombotic or haemorrhagic stroke from combined American and British studies has been estimated to be 37/100 000 per year in women aged 30-44. 50 Attributable risk is the difference in the incidence of cerebrovascular disease between OC users and nonusers. Although an added risk of stroke with high-dose oestrogen oral contraceptives is likely, whether there is any risk with the currently used low-dose oestrogen preparations is yet in question.s! In addition, problems of detection bias and the failure to account for additional risk factors in those with stroke call some of these early conclusions into question.P The question of risk for thrombotic vascular disease in the healthy patient with currently available OCs has not been fully answered, but there is some indication that other stroke risk factors may be important in amplifying any present risk. Tobacco use, in particular, appears to confer a synergistic increase in risk especially in women over 35 years of age. 22 In some cases of stroke associated with both OC and tobacco use, an obliterative vasculopathy occurs, much like Moyamoya disease. 26 • 53 Angiography reveals sites of predilection to be the mid-portion of the cervical internal carotid artery and its terminal intracranial portion, the initial segment of the middle cerebral artery, and distal segments of the intracranial vessels. The pathology is that of a destructive thromboangiitis obliterans with giant cells and subendothelial fibrosis and disintegration. An immunological or allergic angiitis has been suggested as an aetiology for this vasculopathy.
Underlying structural cardiac abnormalities (e.g. mitral valve prolapse) may also increase the risk of infarction in the setting of the relative hypercoagulable state induced by oral contraceptives.w-s' Those with haematological abnormalities (e.g. polycythaemia, sickle cell disease) or with a history of clotting disorders (e.g. history of prior thrombosis or embolism, or inherited clotting disorder such as antithrombin III deficiency) are also at additional risk. 44 ,54 Although some increased risk of thrombotic vascular disease with OC use as previously defined is likely, the extent of this risk in the newer lose-dose preparations has not been adequately analysed. The alterations in lipid metabolism, blood pressure, and glucose tolerance could predispose to atherogenesis, but there is no evidence to indicate that an acceleration in typical atherogenesis occurs with OC use. 56 Also, given the absence of a correlation between duration of oral contraceptive use and incidence of cardiovascular disease or increased risk with past use, accelerated atherosclerosis is an unlikely explanation for the vascular events. 49 • 57 With the current level' of understanding, avoiding the use of oral contraceptives or using low-dose oestrogen preparations in patients with additional stroke risk factors or known structural cardiac abnormalities would be prudent. Tobacco use should be discouraged in any patient, but particularly in the OC user. Oral contraceptives should be discontinued in patients experiencing symptoms of transient ischaemic attack or stroke. Arteriography should be performed in the OC user with stroke, to evaluate for an obliterative vasculopathy.
Pregnancy and the puerperium
The incidence of cerebral infarction during pregnancy and the puerperium has been estimated in previous studies to be anywhere from one in every 481 pregnancies to one in every 26 000 pregnancies. 5 8-62 In a reported series of stroke in young women from Glasgow, Scotland, fully 35% of the strokes occurred during pregnancy or the puerperium, a figure three to four times the expected pregnancy rate for that age group.s-As with exogenous oestrogen use, pregnancy produces a relative procoagulant state. Similarly, there is an excess of several plasma proteins including fibrinogen and several clotting factors (VII, VIII, IX, X and XII), and platelet aggregation is increased. Unlike the OCinduced changes, fibrinolysis is reduced rather than increased, particularly during the second and third trimesters. 43 ,64 These alterations may predispose the patient to venous thrombotic or arterial embolic events, particularly in those with other structural or haematological predisposition to vascular disease. Cardiac disease may result in an embolic stroke by a number of mechanisms. A patient with valvular disease may be at increased risk in the setting of a relative procoagulant state during pregnancy and the puerperium. In addition, an enterococcal infective endocarditis has been reported to occur following the mucosal trauma of delivery or abortion. 65 ,66 For this reason, antibiotic prophylaxis given prior to delivery is advisable in those with known valvular disease including mitral valve prolapse.s? Rheumatic heart disease is more likely to recur during pregnancy resulting in possible embolization of inflammatory valvular vegetations in the acute phase. Alternatively, atrial fibrillation, congestive heart failure, or valvular deformities may cause stroke resulting from chronic rheumatic heart disease. 68, 69 Mural thrombus in the setting of a peripartum cardiomyopathy is another consideration particularly in the older, multiparous patient.??
Paradoxical embolization via a patent foramen ovaIe represents another potential cause of embolic stroke. 8 ,71 ,72 The risk of pelvic or lower extremity thrombophlebitis is particularly increased in the early puerperium after caesarean section, after forceps rotation, or following manual removal of the placenta. Amniotic fluid embolization can create a devastating neurological injury. The clinical presentation is that of an older, multiparous woman with the complication of uterine, cervical, or vaginal tears as a portal of entry.73 There is a rapid deterioration with convulsions, dyspnoea and cyanosis, disseminated intravascular coagulation, shock, and death. Air or fat embolization from an abortion, complicated vaginal delivery, or caesarean section may present with a similar clinical picture. 74, 75 Cervical and intracranial arteriopathy represent another diagnostic category to be considered in the pregnant female. Only about 25% of ischaemic stroke in pregnancy is thought to be related to atherosclerotic disease. 8 ,76 Other arteritides may be exacerbated by pregnancy including Takayasu arteritis and vasculitis associated with connective tissue disease. 77 -79 Moyamoya disease, fibromuscular dysplasia, and spontaneous arterial dissection are additional considerations in a woman of childbearing age, although there is no clear increased incidence of these entities in the pregnant population.
Severe hypotension as a result of blood loss and shock during delivery may result in cerebral watershed infarctions or postpartum pituitary necrosis (Sheehan syndromej.w Eclampsia may cause cerebral ischaemia or haemorrhage as the result of an hypertensive encephalopathy.81
Clinical management of ischaemic cerebrovascular disease during pregnancy and the puerperium

Arterial cerebral ischaemia
The initial evaluation of arterial cerebral ischaemia in pregnancy and the puerperium should include computed tomography (CT) or magnetic resonance imaging, complete blood count, platelet count, blood glucose, serum cholesterol and triglycerides, urinalysis, serological studies, erythrocyte sedimentation rate, prothrombin time and partial thromboplastin time, electrocardiography, echocardiography, chest roentgenography, and carotid Doppler ultrasound. Angiography should be considered if there is no immediate answer with the initial studies. If an underlying coagulopathy is suspected, laboratory evaluation should be delayed for at least 3-6 months after delivery.
Acute anticoagulation should be considered if there is progression of the initial deficit, frequent recurrent transient ischaemic attacks, or basilar thrombosis. Heparin, rather than warfarin, is recommended for long-term anticoagulation during pregnancy for cardioembolic stroke. Heparin does not cross the placental barrier and warfarin may cause haemorrhagic or teratotogenic complications in the fetus. 82 ,83 Intracranial venous occlusive disease Intracranial venous occlusive disease, once thought to be the most common form of cerebral ischaemic injury complicating pregnancy, probably represents only a minority of ischaemic strokes in this setting. 8,6O,63 Over 90% of pregnancy-related intracranial venous thrombosis occurs in the postpartum period (weeks 1-5) with a peak at 8-12 days. 8 In contrast, arterial occlusion tends to appear earlier with 58% occurring during pregnancy and 25% within the first week following delivery. 8 Clinically, intracranial venous thrombosis is marked by symptoms of headache, nausea and vomiting, change in level of consciousness, visual disturbance, and seizures. Weakness and sensory symptoms may be unilateral or bilateral. The clinical course tends to be one of gradual progression and fluctuation rather than the abrupt onset seen with arterial embolic disease. However, an acute onset is more common in obstetrical cases when compared to cerebral venous thrombosis from other causes. 84 Radiological studies are required to distinguish between arterial and venous occlusive disease.
cr scan of the brain may be normal or reveal either bland or haemorrhagic infarctions. With contrast, a gyriform enhancement pattern or intense enhancement of the tentorium and falx may be seen. Previously described radiological signs such as the 'empty delta sign', the 'cord sign', and the 'dense triangle' are helpful if present. 8 The CT scan may be normal in 10-26% of cases. 84 However, its importance lies not only in its identification of venous infarction, but also in the exclusion of other conditions. Magnetic resonance imaging has become the technique of choice for evaluation and monitoring of patients with suspected venous thrombosis because of its noninvasive nature and sensitivity to blood flow. There is a characteristic evolution of the intravascular thrombus on the Tl-and T2-weighted images. 88, 89 In addition, the parenchymal lesions may be viewed more readily than with CT scan. However, angiography, with its demonstration of partial or complete lack of filling .of veins or sinuses, continues to be the gold standard by which to measure other radiological methods of diagnosis. 85.90 Evaluation of the cerebrospinal fluid should be performed if there is any suspicion of underlying meningitis preciptating the thrombosis.
Treatment of cerebral venous thrombosis consists of bed rest, hydration, seizure control, and management of increased intracranial pressure.
Osmotic agents such as mannitol for increased intracranial pressure should be avoided in the pregnant patient if possible, because of potential adverse effects of dehydration for the fetus.f Anticoagulation has been controversial, but recently many authors have recommended it even in the setting of haemorrhagic infarction.85.91-93 The mortality associated with cerebral venous thrombosis in pregnancy is quite variable and may be as high as 30% in recent series.s-However, those who survive seem to have less neurological deficit than patients recovering from arterial insults. 85,94
Conclusions
Ischaemic stroke occurring in the young female carries a unique differential diagnosis which alters the approach to diagnosis and treatment. Oral contraceptive use, pregnancy, and the puerperium may create a procoagulant state which predisposes to arterial and venous thrombotic events. Specific entities predisposing to stroke that occur more frequently in the young female, including several vasculitides, migraine headache, and mitral valve prolapse, should be considered.
